UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase 1 study of PSMA ADC, an antibody‐drug conjugate targeting prostate‐specific membrane antigen, in chemotherapy‐refractory prostate cancer

The Prostate, 2019-05, Vol.79 (6), p.604-613

2019

Volltextzugriff (PDF)

A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin

Clinical and translational science, 2022-09, Vol.15 (9), p.2159-2171

2022

Volltextzugriff (PDF)

Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation

Current therapeutic research, 2023-01, Vol.98, p.100694-100694, Article 100694

2023

Volltextzugriff (PDF)

Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

Clinical and translational science, 2023-01, Vol.16 (1), p.165-174

2023

Volltextzugriff (PDF)

Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials [version 2; peer review: 2 approved]

F1000 research, 2021-01, Vol.10, p.891

2021

Volltextzugriff (PDF)

Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia

Microorganisms (Basel), 2024-06, Vol.12 (6), p.1146

2024

Volltextzugriff (PDF)

Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials [version 1; peer review: 2 approved]

F1000 research, 2021, Vol.10, p.891

2021

Volltextzugriff (PDF)

Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study

Journal of pain and symptom management, 2008-05, Vol.35 (5), p.458-468

2008

Volltextzugriff (PDF)

Immunogenicity and skin clearance recapture in clinical studies of brodalumab

Journal of the American Academy of Dermatology, 2020-02, Vol.82 (2), p.344-351

2020

Volltextzugriff (PDF)

Methylnaltrexone Treatment of Opioid-Induced Constipation in Patients with Advanced Illness

Journal of pain and symptom management, 2009-11, Vol.38 (5), p.683-690

2009

Volltextzugriff (PDF)

Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials

Journal of the American Academy of Dermatology, 2018-01, Vol.78 (1), p.81-89.e5

2018

Volltextzugriff (PDF)

Treatment of Advanced Human Immunodeficiency Virus Type 1 Disease with the Viral Entry Inhibitor PRO 542

Antimicrobial Agents and Chemotherapy, 2004-02, Vol.48 (2), p.423-429

2004

Volltextzugriff (PDF)

S165 Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e118-e119

2022

Volltextzugriff (PDF)

Malignancy Rates in Brodalumab Clinical Studies for Psoriasis

American journal of clinical dermatology, 2020-06, Vol.21 (3), p.421-430

2020

Volltextzugriff (PDF)

Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness

The New England journal of medicine, 2008-05, Vol.358 (22), p.2332-2343

2008

Volltextzugriff (PDF)

S187 A Pooled Analysis of the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Severe Medical Illness: The Impact of Baseline Opioid Equivalent Dose

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S84-S84

2021

Volltextzugriff (PDF)

Characterization of Abdominal Pain During Methylnaltrexone Treatment of Opioid-Induced Constipation in Advanced Illness: A Post Hoc Analysis of Two Clinical Trials

Journal of pain and symptom management, 2011-11, Vol.42 (5), p.754-760

2011

Volltextzugriff (PDF)

Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials

Clinical gastroenterology and hepatology, 2023-03, Vol.21 (3), p.723-731.e9

2023

Volltextzugriff (PDF)

Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study

American journal of clinical dermatology, 2019-12, Vol.20 (6), p.863-871

2019

Volltextzugriff (PDF)

Single-Dose Safety, Pharmacology, and Antiviral Activity of the Human Immunodeficiency Virus (HIV) Type 1 Entry Inhibitor PRO 542 in HIV-Infected Adults

The Journal of infectious diseases, 2000-07, Vol.182 (1), p.326-329

2000

Volltextzugriff (PDF)

Randomized, Double‐Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid‐Induced Constipation in Patients with Chronic Noncancer Pain

Pain practice, 2017-07, Vol.17 (6), p.820-828

2017

Volltextzugriff (PDF)

Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis

Pain medicine (Malden, Mass.), 2023-03, Vol.24 (3), p.341-350

2023

Volltextzugriff (PDF)

Tolerability, Gut Effects, and Pharmacokinetics of Methylnaltrexone Following Repeated Intravenous Administration in Humans

Journal of clinical pharmacology, 2005-05, Vol.45 (5), p.538-546

2005

Volltextzugriff (PDF)

First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis

The Journal of emergency medicine, 2022-02, Vol.62 (2), p.231-239

2022

Volltextzugriff (PDF)

1 – 25 von 722

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(632)
Mit Volltextzugriff
(616)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Phase 1 study of PSMA ADC, an antibody‐drug conjugate targeting prostate‐specific membrane antigen, in chemotherapy‐refractory prostate cancer

A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin

Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation

Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials [version 2; peer review: 2 approved]

Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia

Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials [version 1; peer review: 2 approved]

Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study

Immunogenicity and skin clearance recapture in clinical studies of brodalumab

Methylnaltrexone Treatment of Opioid-Induced Constipation in Patients with Advanced Illness

Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials

Treatment of Advanced Human Immunodeficiency Virus Type 1 Disease with the Viral Entry Inhibitor PRO 542

S165 Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness

Malignancy Rates in Brodalumab Clinical Studies for Psoriasis

Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness

S187 A Pooled Analysis of the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Severe Medical Illness: The Impact of Baseline Opioid Equivalent Dose

Characterization of Abdominal Pain During Methylnaltrexone Treatment of Opioid-Induced Constipation in Advanced Illness: A Post Hoc Analysis of Two Clinical Trials

Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials

Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study

Single-Dose Safety, Pharmacology, and Antiviral Activity of the Human Immunodeficiency Virus (HIV) Type 1 Entry Inhibitor PRO 542 in HIV-Infected Adults

Randomized, Double‐Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid‐Induced Constipation in Patients with Chronic Noncancer Pain

Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis

PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label single‐arm phase 2 study

Tolerability, Gut Effects, and Pharmacokinetics of Methylnaltrexone Following Repeated Intravenous Administration in Humans

First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis

Suchergebnisse filtern